Skip to main content
Wednesday, November 11, 2026Nov 11

Demand for COVID antibody drugs soars in hard-hit states

In this photo provided by Louie Lopez, sick people lie on the floor in a medical facility in Jacksonville, Fla., on Wednesday, Aug. 18, 2021. Lopez took the photo while waiting more than 2.5 hours to get antibody treatment at a facility run by the state. While he waited, he watched the room fill up with extremely sick patients. (Louie Lopez via AP)
In this photo provided by Louie Lopez, sick people lie on the floor in a medical facility in Jacksonville, Fla., on Wednesday, Aug. 18, 2021. Lopez took the photo while waiting more than 2.5 hours to get antibody treatment at a facility run by the state. While he waited, he watched the room fill up with extremely sick patients. (Louie Lopez via AP) In this photo provided by Louie Lopez, sick people lie on the floor in a medical facility in Jacksonville, Fla., on Wednesday, Aug. 18, 2021. Lopez took the photo while waiting more than 2.5 hours to get antibody treatment at a facility run by the state. While he waited, he watched the room fill up with extremely sick patients. (Louie Lopez via AP)
photo In this photo provided by Louie Lopez, sick people lie on the floor in a medical facility in Jacksonville, Fla., on Wednesday, Aug. 18, 2021. Lopez took the photo while waiting more than 2.5 hours to get antibody treatment at a facility run by the state. While he waited, he watched the room fill up with extremely sick patients. (Louie Lopez via AP)

People infected with COVID-19 were captured in a photo this week lying on the floor in pain while waiting for antibody infusions at a treatment site set up inside the library in Jacksonville, Florida.

The image has become a vivid illustration of the huge demand for the once-neglected COVID-19 drugs in the states hit hardest by a summer surge of infections being driven by the highly contagious delta variant.

“They were moaning and obviously in a lot of pain. They were miserable,” said Louie Lopez, who shot the photograph as he waited for more than two hours to receive the treatment.

Antibody treatments remain one of a handful of therapies that can blunt the worst effects of COVID-19, and they are the only option available to people with mild-to-moderate cases who aren’t yet in the hospital.

They have risen in demand in states seeing a spike in infections, including Florida, Louisiana and Texas, where hospitalizations among the unvaccinated are overwhelming the health care system.